Researchers design process to better understand how advanced melanoma adapts to immunotherapy – Science Daily
|
Researchers design process to better understand how advanced melanoma adapts to immunotherapy
Science Daily The findings lay the groundwork for developing new and improved combination therapies for patients who are resistant to stand-alone immunotherapy treatments. Pembrolizumab (marketed as Keytruda) works by signaling the patient's immune system to … |
